Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Amgen Inc (AMGN)  
$319.10 6.24 (1.99%) as of 4:30 Thu 9/26


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 585,690,000
Market Cap: 186.89(B)
Last Volume: 2,555,459 Avg Vol: 2,663,996
52 Week Range: $255.7 - $335.97
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
    S&P COMPOSITE 1500     NASDAQ BIOTECHNOLOGY
    NASDAQ COMPOSITE     NASDAQ-100
    S&P 100     S&P 500
    NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  442
Guru Rank Value     : 4.5
Guru Occurances    : 3

 

            6 Months   1 Year   2 Year  
 
Company Profile   Amgen is a biotechnology company that focuses on discovering, developing, manufacturing and delivering human therapeutics. Co.'s principal products are Enbrel® (etanercept), Prolia® (denosumab), Otezla® (apremilast), XGEVA® (denosumab), Neulasta® (pegfilgrastim), Aranesp® (darbepoetin alfa), Repatha® (evolocumab), KYPROLIS® (carfilzomib) and Nplate® (romiplostim). Co. also markets a number of other products, including among other, MVASI® (bevacizumab-awwb), Vectibix® (panitumumab), KANJINTI® (trastuzumab-anns), EVENITY® (romosozumab-aqqg), EPOGEN® (epoetin alfa), BLINCYTO® (blinatumomab), AMGEVITA™ (adalimumab), Aimovig® (erenumab-aooe), Parsabiv® (etelcalcetide) and NEUPOGEN® (filgrastim).

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 0 2,117 14,213 24,703
Total Sell Value $0 $662,802 $3,963,214 $6,744,849
Total People Sold 0 1 2 4
Total Sell Transactions 0 1 3 6
End Date 2024-06-27 2024-03-26 2023-09-26 2022-09-26

   
Records found: 2210
  Page 36 of 89  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Mcnamee Brian M EVP   •       •      –    2015-03-27 4 D $160.55 $2,330,704 D/D (14,517) 80,952     -
   Hooper Anthony C EVP, Global Commercial Ops.   •       •      –    2015-03-27 4 D $160.55 $4,595,583 D/D (28,624) 166,909     -
   Harper Sean E EVP, Research & Development   •       •      –    2015-03-27 4 D $160.55 $4,595,583 D/D (28,624) 75,920     -
   Bradway Robert A Chairman, CEO and President   •       •      –    2015-03-27 4 D $160.55 $11,118,569 D/D (69,253) 281,854     -
   Balachandran Madhavan EVP, Operations   •       •      –    2015-03-27 4 GA $0.00 $0 I/I 7,614 55,369     -
   Balachandran Madhavan EVP, Operations   •       •      –    2015-03-27 4 GD $0.00 $0 D/D 7,614 35,799     -
   Balachandran Madhavan EVP, Operations   •       •      –    2015-03-27 4 D $160.55 $1,334,331 D/D (8,311) 43,413     -
   Hooper Anthony C EVP, Global Commercial Ops.   •       •      –    2015-03-11 4 D $153.58 $4,229,593 D/D (27,540) 195,148     -
   Such Annette Louise CAOOfficer   •       –      –    2015-03-09 3 IO $0.00 $0 D/D 0 8,760     -
   Tross Stuart A SVP, Human Resources   •       •      –    2015-03-04 4 A $0.00 $0 D/D 8,324 28,561     -
   Scott David J SVP, Gen. Counsel & Secy.   •       •      –    2015-03-04 4 A $0.00 $0 D/D 38,732 116,962     -
   Piacquad David SVP, Business Development   •       •      –    2015-03-04 4 A $0.00 $0 D/D 9,459 36,321     -
   Mcnamee Brian M EVP   •       •      –    2015-03-04 4 A $0.00 $0 D/D 28,169 95,214     -
   Patton Cynthia M SVP & CCO   •       •      –    2015-03-04 4 A $0.00 $0 D/D 7,567 25,006     -
   Harper Sean E EVP, Research & Development   •       •      –    2015-03-04 4 A $0.00 $0 D/D 54,577 104,162     -
   Bradway Robert A Chairman, CEO and President   •       •      –    2015-03-04 4 A $0.00 $0 D/D 132,045 350,147     -
   Hooper Anthony C EVP, Global Commercial Ops.   •       •      –    2015-03-04 4 A $0.00 $0 D/D 107,354 222,688     -
   Balachandran Madhavan EVP, Operations   •       •      –    2015-03-04 4 A $0.00 $0 D/D 15,845 51,352     -
   Tross Stuart A SVP, Human Resources   •       •      –    2015-03-03 4 S $157.74 $696,427 D/D (4,415) 20,237     -
   Baltimore David Director   •       •      –    2015-03-02 4 S $158.76 $579,011 D/D (3,647) 31,159     -
   Hooper Anthony C EVP, Global Commercial Ops.   •       •      –    2015-03-02 4 D $157.72 $507,070 D/D (3,215) 115,334     -
   Baltimore David Director   •       •      –    2015-02-19 4 D $155.78 $210,770 D/D (1,353) 34,806     -
   Baltimore David Director   •       •      –    2015-02-19 4 OE $42.13 $210,650 D/D 5,000 36,159     -
   Bradway Robert A Chairman, CEO and President   •       •      –    2015-02-11 4 S $152.69 $3,359,116 D/D (22,000) 218,102     -
   Bradway Robert A Chairman, CEO and President   •       •      –    2015-02-11 4 OE $42.13 $3,538,920 D/D 84,000 240,102     -
  2210 Records found
  Previous  30  31  32  33  34  35  36  37  38  39  Next   
  Page 36 of 89
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us